Table 1.
Demographic and clinical data stratified by anhedoniaa
| Total sample (n = 368) | Anhedonia (n = 74) | No anhedonia (n = 294) | P | |
|---|---|---|---|---|
| Socio-demographics | ||||
| Males | 290 (78.8) | 58 (78.4) | 232 (78.9) | .92 |
| Age, mean (SD) | 58.0 (10.2) | 57.7 (10.1) | 58.1 (10.3) | .77 |
| Having a partner | 330 (89.7) | 62 (83.8) | 268 (91.2) | .06 |
| Clinical variables | ||||
| Cardiac event prior to index eventb | 299 (81.3) | 60 (81.1) | 239 (81.3) | .97 |
| Diabetes Mellitus | 54 (14.7) | 13 (17.6) | 41 (13.9) | .43 |
| Dyslipidemia | 185 (50.3) | 42 (56.8) | 143 (48.6) | .21 |
| Hypertension | 122 (33.2) | 27 (36.5) | 95 (32.3) | .50 |
| COPDc | 28 (7.6) | 6 (8.1) | 22 (7.5) | .86 |
| Currently smoking | 32 (8.7) | 13 (17.6) | 19 (6.5) | .002d |
| Medication | ||||
| ACE-inhibitors | 215 (58.4) | 47 (63.5) | 168 (57.1) | .32 |
| Calcium-antagonists | 42 (11.4) | 5 (6.8) | 37 (12.6) | .16 |
| Nitrates | 118 (32.1) | 15 (20.3) | 103 (35.0) | .02* |
| Statins | 298 (81.0) | 62 (83.8) | 236 (80.3) | .49 |
| Aspirin | 277 (75.3) | 57 (77.0) | 220 (74.8) | .70 |
| Diuretics | 66 (17.9) | 10 (13.5) | 56 (19.0) | .27 |
| Anti-depressants | 15 (4.1) | 10 (13.5) | 5 (1.7) | <.001d |
| Anxiolytics | 31 (8.4) | 12 (16.2) | 19 (6.5) | .007d |
| Cardiac rehabilitation components e | ||||
| Introduction | 144 (44.4) | 29 (45.3) | 115 (44.2) | .88 |
| Risk factors | 251 (77.0) | 46 (70.8) | 205 (78.5) | .18 |
| Nutrition/Dietary advice | 238 (73.0) | 43 (66.2) | 195 (74.7) | .16 |
| Medication | 196 (59.0) | 38 (57.6) | 158 (59.4) | .79 |
| Physical exercise | 327 (98.5) | 64 (97.0) | 263 (98.9) | .26 |
| Stress management | 61 (18.4) | 8 (1214) | 53 (20.0) | .14 |
| Smoking cessation | 26 (7.8) | 4 (6.1) | 22 (8.3) | .55 |
| Weight loss | 53 (16.0) | 11 (16.7) | 42 (15.8) | .86 |
| Individual counseling | 48 (14.5) | 14 (21.2) | 34 (12.8) | .08 |
aResults are presented as n(%) unless otherwise stated
bCABG, MI, or PCI
cCOPD = Chronic obstructive pulmonary disease
d P < .05
eDue to missing data for 36–44 patients, analyses were conducted on available data